Tenofovir nephrotoxicity: focusing research questions and putting them into clinical context.
Szczech
Lynda Anne
LA
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000503:physiopathology*; D007684:Kidney Tubules / Q000187:drug effects; D063065:Organophosphonates / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D000068698:Tenofovir
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine